Ukraine's pharmacies propose creating ad hoc group to provide medicines amid spread of COVID-19
KYIV. April 2 (Interfax-Ukraine) – Domestic pharmaceutical manufacturers have proposed creating a coordination group under the president of Ukraine with the participation of central executive authorities, industry associations and drug manufacturers to quickly resolve the issues of providing medicines during the spread of coronavirus infection.
Pharmaceutical companies that are members of the Manufacturers of Medications of Ukraine Association said this at a press conference at the Interfax-Ukraine agency.
According to association president Petro Bahriy, the working group, in particular, could quickly resolve the problems associated with the increased demand for certain groups of drugs, a shortage of a number of active pharmaceutical ingredients, interruptions in the logistics of medicines, as well as the issues of patent law.
"Today, the enterprises involved in the production of active pharmaceutical ingredients have been stopped, there are problems with the supply of substances, packaging materials, problems with the logistics of medicines, so today it would be very good to form a headquarters and plan our work in the government and the president's office in such a way as to help domestic manufacturers cope with these challenges and provide the population of Ukraine with medicines," he said.
The chairperson of the board of PJSC Indar, Liubov Vyshnevska, in turn, noted that the pharmaceutical companies faced a number of problems, including quotas for alcohol without excise taxes.
"Quotas, not even during the epidemic, but in ordinary life, are the Stone Age. Pharmaceutical manufacturers with production licenses should get enough alcohol," she said.